Study Comparing On-Demand Treatment With Two Prophylaxis Regimens Of BeneFIX In Patients With Severe Hemophilia B

NCT00364182 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Hemophilia B

Interventions

DRUG: Recombinant Coagulation Factor IX (BeneFIX)
DRUG: Recombinant Coagulation Factor IX (BeneFIX)

Sponsor

Pfizer